ATLANTA, Oct. 25, 2017 -- Mueller Water Products, Inc. (NYSE:MWA) today announced that its Board of Directors has declared a quarterly dividend of four cents ($0.04) per share, payable on or about November 20, 2017 to stockholders of record as of the close of business on November 10, 2017.
About Mueller Water Products
Mueller Water Products, Inc. is a pure play water products company and a leading manufacturer and marketer of products and services used in the transmission, distribution and measurement of water in North America. Our broad product and service portfolio includes engineered valves, fire hydrants, metering products and systems, leak detection and pipe condition assessment. We help municipalities increase operational efficiencies, improve customer service and prioritize capital spending, demonstrating why Mueller Water Products is Where Intelligence Meets Infrastructure®. For more information about Mueller Water Products, visit www.muellerwaterproducts.com.
Investor Contact: Martie Edmunds Zakas
Sr. Vice President – Strategy, Corporate Development & Communications
770-206-4237
[email protected]
Media Contact: Yolanda Kokayi
Director - Corporate Communications & Public Affairs
770-206-4131
[email protected]


Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 



